Association between Proinflammatory Cytokines and Anxiety and Depression Symptoms in Rheumatoid Arthritis Patients: A Cross-sectional Study

Rheumatoid arthritis (RA) patients have a greater prevalence of anxiety and depression. Proinflammatory cytokines are elevated in RA. We aim to evaluate the association between systemic inflammation in RA and anxiety and depression. There were 31 RA patients, 16 with active disease activity and 15 in remission state; they were assessed using the Hospital Anxiety and Depression Scale and for RA disease activity using Disease Activity Score of 28 joints (DAS28) – CRP (C-reactive protein). Serum proinflammatory cytokines were measured, including interleukin (IL)-6, IL-17, and Tumour Necrosis Factor-alpha (TNF-α). Among 31 patients, ten patients showed anxiety symptoms, 19 patients showed depression symptoms, and two displayed mixed symptoms. Serum TNF-α levels were significantly higher in active disease than in the remission group (p-value 0.006). There was no association or correlation between proinflammatory cytokines to anxiety and depression symptoms in the active disease and remission groups. This suggests that other factors besides disease activity and state of systemic inflammation may cause anxiety and depression in RA patients.

[1]  M. R. Pereira,et al.  A Systematic Review of Nutritional Interventions on Key Cytokine Pathways in Rheumatoid Arthritis and Its Implications for Comorbid Depression: Is a More Comprehensive Approach Required? , 2022, Cureus.

[2]  Xuesong Liu,et al.  Serum tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, and interleukin‐17 relate to anxiety and depression risks to some extent in non‐small cell lung cancer survivor , 2021, The clinical respiratory journal.

[3]  Chunhai Zhang.  Flare-up of cytokines in rheumatoid arthritis and their role in triggering depression: Shared common function and their possible applications in treatment (Review) , 2020, Biomedical reports.

[4]  C. Edwards,et al.  Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review , 2020, Rheumatology and Therapy.

[5]  Alexey P Sarapultsev,et al.  Low glucocorticoids in stress-related disorders: the role of inflammation , 2020, Stress.

[6]  S. Hider,et al.  The association between anxiety and disease activity and quality of life in rheumatoid arthritis: a systematic review and meta-analysis , 2020, Clinical Rheumatology.

[7]  S. Korte,et al.  Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms , 2019, Rheumatology.

[8]  S. Suhardjono,et al.  Anxiety and depression among caregivers of hemodialysis patients at the Indonesian national referral hospital , 2018, Medical Journal of Indonesia.

[9]  M. Bernardes,et al.  Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis , 2018, Journal of immunology research.

[10]  E. Choy,et al.  Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis , 2017, Rheumatology.

[11]  Milena Flória-Santos,et al.  Elevated serum levels of proinflammatory cytokines potentially correlate with depression and anxiety in colorectal cancer patients in different stages of the antitumor therapy , 2017, Cytokine.

[12]  Naomi M Simon,et al.  Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study. , 2017, Journal of psychosomatic research.

[13]  U. Vogel,et al.  Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis , 2017, The Pharmacogenomics Journal.

[14]  P. Miossec,et al.  Selected cytokine pathways in rheumatoid arthritis , 2017, Seminars in Immunopathology.

[15]  J. Sturgeon,et al.  Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways , 2016, Nature Reviews Rheumatology.

[16]  K. Stein,et al.  Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety. , 2015, Journal of psychosomatic research.

[17]  J. Wolchok,et al.  Depression, cytokines, and pancreatic cancer , 2014, Psycho-oncology.

[18]  M. Irwin,et al.  From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. , 2014, Psychological bulletin.

[19]  Q. Luo,et al.  Sputum interleukin-6, tumor necrosis factor-α and Salivary cortisol as new biomarkers of depression in lung cancer patients , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  M. Hotopf,et al.  The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis , 2013, Rheumatology.

[21]  E. Yelin,et al.  Depression in patients with rheumatoid arthritis: description, causes and mechanisms. , 2011, International journal of clinical rheumatology.

[22]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[23]  T. Furukawa,et al.  Depression, inflammation, and pain in patients with rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[24]  T. Matsui,et al.  Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan , 2007, Annals of the rheumatic diseases.

[25]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  J. E. Hewett,et al.  Anxiety in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[27]  H. Anisman,et al.  Cytokines, stress and depressive illness: brain‐immune interactions , 2003, Annals of medicine.

[28]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[29]  L. Lix,et al.  Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease. , 2018, General hospital psychiatry.